EMS Group: Revenue Decline in Q2 2026

EMS Group announced revenues of €12.1 million for the second quarter of 2026, a 4% decrease compared to the previous year. The Radiology division experienced a 9% decline, despite growth in private label sales. Overall group sales were hampered by geopolitical tensions and weak demand in Europe.

The bone densitometry sector, however, posted 32% growth in the second quarter, contrasting with a difficult start to the year. For the first half of the year, consolidated revenue reached €22.1 million, a 6% decrease compared to the first half of 2025.

The outlook for the remainder of 2026 remains positive, with EMS Group forecasting increased activity, particularly in North America, despite current economic and geopolitical challenges.